102 related articles for article (PubMed ID: 34724663)
21. OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1.
Yang Y; Jia S; Zhu N; Xiao X; Ma Y; Tu K; Guo Y; Xu Q
Biol Direct; 2024 Apr; 19(1):31. PubMed ID: 38658981
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive analysis of the oncogenic and prognostic role of TBC1Ds in human hepatocellular carcinoma.
Zhang P; Zhu L; Pan X
PeerJ; 2024; 12():e17362. PubMed ID: 38766486
[TBL] [Abstract][Full Text] [Related]
23. KIF11 Promotes Proliferation of Hepatocellular Carcinoma among Patients with Liver Cancers.
Hu ZD; Jiang Y; Sun HM; Wang JW; Zhai LL; Yin ZQ; Yan J
Biomed Res Int; 2021; 2021():2676745. PubMed ID: 33490265
[TBL] [Abstract][Full Text] [Related]
24. [High expression of UBE2S promotes progression of hepatocellular carcinoma by increasing cancer cell stemness].
Chen H; Li Z; Wang M; Lu L; Tang Q; Luo L
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):455-464. PubMed ID: 38597436
[TBL] [Abstract][Full Text] [Related]
25. TACC3 is an independent prognostic marker, and knockdown of TACC3 enhances the efficacy of CDK1 inhibitor RO3306 in liver cancer cells.
Guo E; Yang J; Li L; Chen J; Liu H
J Biochem Mol Toxicol; 2023 Sep; 37(9):e23402. PubMed ID: 37341435
[TBL] [Abstract][Full Text] [Related]
26. Fanconi Anemia Complementary Group A (FANCA) Facilitates the Occurrence and Progression of Liver Hepatocellular Carcinoma.
Huang FD; Zhong YP; Sun GY; Xu QJ; Xing ZY; Chen KH; Liao LS; Dong MY
Dig Dis Sci; 2024 Mar; 69(3):1035-1054. PubMed ID: 38282187
[TBL] [Abstract][Full Text] [Related]
27. Identification of ASF1A and HJURP by global H3-H4 histone chaperone analysis as a prognostic two-gene model in hepatocellular carcinoma.
Liu Y; Liu S; Jing R; Li C; Guo Y; Cai Z; Xi P; Dai P; Jia L; Zhu H; Zhang X
Sci Rep; 2024 Apr; 14(1):7666. PubMed ID: 38561384
[TBL] [Abstract][Full Text] [Related]
28. High expression of Ran binding protein 1 predicts poor outcomes in hepatocellular carcinoma patients: a Cancer Genome Atlas database analysis.
Wei Z; Duan X; Li Q; Li Q; Wang Y
J Gastrointest Oncol; 2021 Dec; 12(6):2966-2984. PubMed ID: 35070423
[TBL] [Abstract][Full Text] [Related]
29. High expression of the
Fei ZY; Wang WS; Li SF; Zi JJ; Yang L; Liu T; Ao S; Liu QQ; Cui QH; Yu M; Xiong W
J Gastrointest Oncol; 2020 Dec; 11(6):1291-1304. PubMed ID: 33457002
[TBL] [Abstract][Full Text] [Related]
30. Distinct molecular etiologies of male and female hepatocellular carcinoma.
Natri HM; Wilson MA; Buetow KH
BMC Cancer; 2019 Oct; 19(1):951. PubMed ID: 31615477
[TBL] [Abstract][Full Text] [Related]
31. Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma Tissues.
Ye WY; Lu HP; Li JD; Chen G; He RQ; Wu HY; Zhou XG; Rong MH; Yang LH; He WY; Pang QY; Pan SL; Pang YY; Dang YW
Cancer Biother Radiopharm; 2023 Dec; 38(10):684-707. PubMed ID: 34619053
[No Abstract] [Full Text] [Related]
32. High Ki67 Gene Expression Is Associated With Aggressive Phenotype in Hepatocellular Carcinoma.
Ramos-Santillan V; Oshi M; Nelson E; Endo I; Takabe K
World J Oncol; 2024 Apr; 15(2):257-267. PubMed ID: 38545476
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic and prognostic significance of small nuclear ribonucleoprotein Sm D1 aberrantly high expression in hepatocellular carcinoma.
Wang H; Xu F; Lu L; Yang F; Huang X; Lv L; Hu H; Jiang Y
J Cancer; 2022; 13(1):184-201. PubMed ID: 34976182
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma.
Qin Z; Zhu F; Xie B; Zhang Y; Yuan M; Yang P; Zhang L; Wei J; Zhu Z; Qian Z; Wang Z; Fan L; Xu S; Tan Y; Qian J
Transl Oncol; 2024 Jan; 39():101816. PubMed ID: 37925796
[TBL] [Abstract][Full Text] [Related]
35. Heat shock protein family A member 8 serving as a co-activator of transcriptional factor ETV4 up-regulates PHLDA2 to promote the growth of liver cancer.
Wang S; Wang YF; Yang G; Zhang HH; Yuan HF; Hou CY; Zhao LN; Suo YH; Sun J; Sun LL; Lv P; Sun Y; Zhang NN; Zhang XD; Lu W
Acta Pharmacol Sin; 2023 Dec; 44(12):2525-2536. PubMed ID: 37474643
[TBL] [Abstract][Full Text] [Related]
36. E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma.
Chida K; Oshi M; Roy AM; Yachi T; Nara M; Yamada K; Matsuura O; Hashizume T; Endo I; Takabe K
Surgery; 2023 Aug; 174(2):307-314. PubMed ID: 37198038
[TBL] [Abstract][Full Text] [Related]
37. E2F-mediated POLA2 upregulation is correlated with macrophage infiltration and poor prognosis in hepatocellular carcinoma.
Teng Y; Liu R
Transl Cancer Res; 2024 Apr; 13(4):1848-1860. PubMed ID: 38737703
[TBL] [Abstract][Full Text] [Related]
38. Prognostic and Immunotherapeutic Predictive Value of CAD Gene in Hepatocellular Carcinoma: Integrated Bioinformatics and Experimental Analysis.
Wang X; Feng JK; Mao FF; Hou YC; Zhang YQ; Liu LH; Wei Q; Sun JX; Liu C; Shi J; Cheng SQ
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38683442
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of INTS family related to expression, prognosis, diagnosis and immune features in hepatocellular carcinoma.
Wang B; Du Z; Lin C; Liu D; Guo J; Shi J; Wang X
Heliyon; 2024 May; 10(9):e30244. PubMed ID: 38720706
[TBL] [Abstract][Full Text] [Related]
40. Spinster Homologue 2 Expression Correlates With Improved Patient Survival in Hepatocellular Carcinoma Despite Association With Lymph-Angiogenesis.
Sarkar J; Oshi M; Satyananda V; Chida K; Yan L; Maiti A; Hait N; Endo I; Takabe K
World J Oncol; 2024 Apr; 15(2):181-191. PubMed ID: 38545475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
